review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | John D Reveille | Q67485113 |
Maria E Suarez-Almazor | Q89359620 | ||
P2093 | author name string | Gabriele Valentini | |
Peter A Merkel | |||
Daniel E Furst | |||
Philip J Clements | |||
OMERACT 6 | |||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1630-1647 | |
P577 | publication date | 2003-07-01 | |
P1433 | published in | The Journal of Rheumatology | Q7743623 |
P1476 | title | Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6 | |
P478 | volume | 30 |
Q49860214 | A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography: Outcome Measures for Systemic Sclerosis-Related Raynaud's Phenomenon. |
Q52374296 | A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis. |
Q30359351 | A preliminary study of skin ultrasound in diffuse cutaneous systemic sclerosis: Does skin echogenicity matter? |
Q46755874 | A randomized unblinded trial of cyclophosphamide versus azathioprine in the treatment of systemic sclerosis |
Q47835767 | Assessment of skin involvement in systemic sclerosis |
Q60954541 | Behaviour change interventions for the management of Raynaud's phenomenon: a systematic literature review |
Q37730018 | Biomarkers in systemic sclerosis |
Q36175068 | Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force |
Q37460792 | Development of a provisional core set of response measures for clinical trials of systemic sclerosis |
Q37931049 | Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice? |
Q37993979 | Graft-versus-host disease: part II. Management of cutaneous graft-versus-host disease |
Q35784089 | Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise |
Q35638054 | Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study |
Q46256178 | Muscle involvement in systemic sclerosis: points to consider in clinical trials |
Q39322803 | Musculoskeletal Involvement in SSc Is Associated with Worse Scores on Short Form-36 and Scleroderma Health Assessment Questionnaire and Lower Tumor Necrosis Factor-α Gene Expression in Peripheral Blood Mononuclear Cells |
Q37586400 | New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN). |
Q36821503 | Outcome measures in systemic sclerosis: an update on instruments and current research |
Q33607935 | Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective |
Q35977294 | Patterns and predictors of change in outcome measures in clinical trials in scleroderma: an individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis |
Q45938471 | Points to consider for designing trials in systemic sclerosis patients with arthritic involvement. |
Q45995241 | Points to consider in renal involvement in systemic sclerosis. |
Q48442372 | Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools |
Q38180018 | Quantitating skin fibrosis: innovative strategies and their clinical implications |
Q34109827 | Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis |
Q35851777 | Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis |
Q30372810 | Skin imaging in systemic sclerosis. |
Q35638700 | Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test |
Q36758822 | The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis |
Q40002833 | The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis |
Q34979209 | The association of body image dissatisfaction and pain with reduced sexual function in women with systemic sclerosis |
Q37460765 | The symptom burden index: development and initial findings from use with patients with systemic sclerosis |
Q34727670 | Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards |
Q37460808 | Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial |
Q79804182 | [Systemic sclerosis - diagnosis and classification] |
Search more.